Table 1.

Treatment plan overview. Treatment field data from 29 patients were collected to correlate WET to the dosimetric effects of respiratory motion. The absolute displacement of the tumor centroid during respiration between inhale and exhale phase of the 4D CT is labeled as “motion.”

Patient #	Motion (mm)	Rx (Gy)	Location	ITV(cc)	Fields/Plan
1	3	74	RUL	786	5
2	4	74	RUL	510	3
3	5	74	RUL	574	4
4	6	74	LUL	308	3
5	6	74	RUL	1205	2
6	6	74	RUL	162	3
7	7	66	RUL	625	2
8	7	66	LLL	343	5
9	7	74	LLL	314	3
10	8	66	RUL	630	3
11	8	74	LLL	247	3
12	8	74	RUL	249	3
13	9	74	RLL	311	2
14	9	66	RLL	239	3
15	9	74	RLL	168	3
16	10	66	RLL	493	3
17	12	74	RUL	656	3
18	12	60	LUL	264	3
19	13	74	RLL	213	3
20	17	74	RLL	212	2
21	9	74	LUL	79	2
22	9	66	RUL	132	3
23	10	74	LLL	103	3
24	9	60	LUL	146	3
25	11	74	RUL	293	2
26	6	74	LLL	41	3
27	4	66	RLL	239	3
28	5	74	RUL	196	4
29	8	74	LLL	225	3

$\text{Rx}=\text{prescription dose}$; $\text{ITV}=\text{internal target volume}$; $\text{RLL}=\text{right lower lobe}$; $\text{RUL}=\text{right upper lobe}$; $\text{LLL}=\text{left lower lobe}$; $\text{LUL}=\text{left upper lobe}$.